NPPA and heart disorder: Besides, exogenous synthetic ANP has been shown to protect from endothelial barrier dysfunction in in vivo and in vitro models of lung injury [18] and the therapeutical relevance of these experimental observations has been shown in intensive care patients without heart disease, where intravenous ANP infusion diminished pulmonary vascular permeability and pulmonary edema [18].